Evaluation of outcomes of a medication therapy management program for patients with diabetes

Journal of the American Pharmacists Association

Volumn 52, Issue 4, 2012, Pages 519-523

  Pinto, Sharrel L ^a   Bechtol, Robert A ^a   Partha, Gautam ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Community pharmacy; Diabetes; Hypertension; Medication therapy management; Pharmaceutical care

Indexed keywords

CAFFEINE; HEMOGLOBIN A1C; INFLUENZA VACCINE; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; EXERCISE; HEART RATE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICATION THERAPY MANAGEMENT; OPHTHALMOLOGIST; PHARMACIST; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD PRESSURE; DRUG EFFECT; HEALTH CARE QUALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY;

BLOOD PRESSURE; DIABETES MELLITUS; HUMANS; LONGITUDINAL STUDIES; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871878275     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.10098     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Diabetes successes and opportunities for population-based prevention and control: at a glance 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
2. Planas LG, Crosby KM, Mitchell KD, et al. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164-70.
3. Cranor C, Bunting B, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
4. Bunting B, Smith B, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23-31.
5. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49:383-91.
6. Johannigman MJ, Leifheit M, Bellman N, et al. Medication therapy management and condition care services in a community-based employer setting. Am J Health Syst Pharm. 2010;67:1362-7.
7. Wagner E, Sandhu N, Newton K, et al. Effect of improved glycemic control on health care cost and utilization. JAMA. 2001;285:182-9.
8. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
9. Moisey L, Kacker S, Bickerton A, et al. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr. 2008;87:1254-61.
10. Campbell NR, Ashley MJ, Carruthers SG. Lifestyle modifications to prevent and control hypertension: recommendations on alcohol consumption. CMAJ. 1999;160(9 suppl):S13-20.
11. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003;45:405-13.
12. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77:1289-303.
13. Macek MD, Taylor GW, Tomar SL. Dental care visits among dentate adults with diabetes, United States, 2003. J Public Health Dent. 2008;68:102-10.
14. Odegard PS, Goo A, Hummel J, et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433-40.